| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.9M | +0.5% |
| Cost of Revenue | $12.3M | +3.5% |
| Gross Profit | $14.6M | -1.8% |
| R&D Expense | $9.8M | -5.0% |
| SG&A Expense | $17.2M | +22.4% |
| Operating Income | -$24.7M | -13.3% |
| Net Income | -$24.0M | -16.1% |
| EPS (Basic) | -$0.30 | -11.1% |
| EPS (Diluted) | -$0.30 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.2M | -38.4% |
| Accounts Receivable | $3.8M | +0.1% |
| Inventory | $8.3M | -1.1% |
| Current Assets | $26.4M | -20.5% |
| Total Assets | $46.7M | +11.5% |
| Current Liabilities | $21.6M | +63.1% |
| Total Liabilities | $35.3M | +76.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | +7.0% |
| Investing Cash Flow | $74K | -99.6% |
| Financing Cash Flow | $297K | +266.7% |
| -11.1% |
| Stockholders' Equity |
| $6.1M |
| -62.8% |